Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types. - Wikidata - wikimedia - TriplyDB

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.

http://www.wikidata.org/entity/Q34457638

about

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials The influence of subclonal resistance mutations on targeted cancer therapy Next-generation sequencing: hype and hope for development of personalized radiation therapy?Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer Cell-free DNA as a diagnostic marker for cancer: current insights Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?DNA Sequence Analysis in Clinical Medicine, Proceeding Cautiously.Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer Circulating Cell-Free Tumour DNA in the Management of Cancer.Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis.Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.Ovarian cancer treatment: The end of empiricism?Efficient Capture and Isolation of Tumor-Related Circulating Cell-Free DNA from Cancer Patients Using Electroactive Conducting Polymer Nanowire Platforms Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers.Circulating tumor DNA detection in lung cancer patients before and after surgery Liquid Biopsies for Cancer: Coming to a Patient near You.Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma.Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.Saliva Liquid Biopsy for Point-of-Care Applications.Cancer diagnostics: The journey from histomorphology to molecular profiling.Circulating biomarkers for gliomas.Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics.Non-Coding RNAs in Thyroid Cancer.Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.Catalog of genetic progression of human cancers: breast cancer.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.Pathologists and liquid biopsies: to be or not to be?Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.Liquid Biopsy in Non-Small Cell Lung Cancer.

P2860

Q26746010-793401C1-DD1E-4A6D-B960-BF7B571D4759 Q26776394-F3085C4F-62AF-4B30-823E-F454ADAC01C1 Q26781693-958B0450-A380-4D44-87E3-484236DADBE2 Q26796485-34941EB4-1262-4743-870F-949D909768B0 Q28067582-17474BED-D90C-40D6-AB78-5B2FB49A9E60 Q28074556-6203E915-86C2-43AB-A4E3-BDE0473AA39E Q28077340-17129E58-4DDA-45BA-BCFE-7572BCD0AC66 Q33627712-83CE337D-B844-4C31-80DC-46BE963723D5 Q33637346-8B3B9A0A-120F-4DCC-BA9D-BA2EA06B360B Q34550417-208323F5-070F-4615-BBE4-8914E4D11C41 Q35615320-19F8410C-DCBD-4AB3-A333-FB22A6535725 Q35814162-8465EED1-2068-4F8A-B35E-18068A56E59B Q35916109-D4C440C0-30C3-4E65-B5D3-7821CDD4B33C Q36087929-584CF9C9-88BF-4C04-A5F2-2DCC1B4DE3D7 Q36132165-8F84EF89-8FBA-4CC3-984A-76D97BD5ECCE Q36242936-400FCC7B-EEC1-4B7B-8E1A-C0B74A8C29DD Q36376138-45E1350D-FE8A-4398-90F4-159DC6C5D593 Q36554444-C97C33BF-74CD-42B5-9D8B-52458D028808 Q36882961-61B61005-D588-4B93-8E95-D9C34CA8D7BE Q37110941-460092B7-CD31-4742-AFA3-8FE2815785A6 Q37264643-F3597D01-0115-4B89-943D-17E1E0ED5038 Q37628173-6601C986-86B7-4A9B-BD63-4A596B0A1A12 Q37687034-4DEC9AD3-45BE-4585-8877-CEA306F28C59 Q37687088-58B423E0-A25B-43B2-AFA3-DF2FFB184E47 Q37709234-00FD3175-2A0D-4197-AE26-4708DC6776EC Q37747010-BE153BD7-A0B2-4C62-A7BC-A9DDA1A5E225 Q38559476-3199E068-0C4E-488E-B63B-877A806639DE Q38586617-6DD284FF-8B07-4093-89E3-60E1B582E634 Q38633504-B92F2BF0-8470-4319-8CBB-582DE8332D2A Q38640437-DA29A7EF-775B-4458-ACC9-C8722B5B3D10 Q38723755-9BD7B384-97F9-449F-A852-F9246EFF903E Q38726457-478CBC7B-BC0D-4988-8C00-57ADD6276E27 Q38764251-24FF2ADF-82E0-44E9-BD97-3BB8432B8AD7 Q38770935-9B15649E-0936-47F2-993C-2FC92439FEF5 Q38824891-7CEE73C3-39F4-4942-B050-5D76D92E30EB Q38920745-107B2AA7-122D-498D-A33A-64A8BF658A0D Q38922208-CB563AA2-86E1-464C-9AA1-B768F4FF1D3A Q38935060-4251C246-9702-4359-83F9-C0DA3A026A5F Q39051797-5E510ADE-3552-4E95-9887-C667206ABE17 Q39076207-6E1BB19B-6F04-4B8D-8868-665DC787F6EA

P2860

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.

http://www.wikidata.org/entity/Q34457638

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating tumor DNA as a non ...... trial across all tumor types.

@ast

Circulating tumor DNA as a non ...... trial across all tumor types.

@en

Circulating tumor DNA as a non ...... trial across all tumor types.

@nl

type

label

Circulating tumor DNA as a non ...... trial across all tumor types.

@ast

Circulating tumor DNA as a non ...... trial across all tumor types.

@en

Circulating tumor DNA as a non ...... trial across all tumor types.

@nl

prefLabel

Circulating tumor DNA as a non ...... trial across all tumor types.

@ast

Circulating tumor DNA as a non ...... trial across all tumor types.

@en

Circulating tumor DNA as a non ...... trial across all tumor types.

@nl

P1433

Q34457638-B44574DF-F459-4340-B398-EF5F95E46827

P1476

Q34457638-0703C9C3-20B4-4B63-81AE-E924896128AE

P2093

Q34457638-118240C0-B65B-4FCB-B169-597053C9EB44

Q34457638-1D61DE58-7C20-4DBF-890F-81C18A8F23FC

Q34457638-1F0A786E-C39A-44C6-ABE4-BFA3748F2B26

Q34457638-3639FFE8-220E-4D1A-AB44-99119D4C586A

Q34457638-3B239AE3-3BD3-430D-9CD6-23415B56B7A6

Q34457638-4691A51E-D3C9-48E2-9E5F-87294F0C17CA

Q34457638-632A577F-6FA4-4BAB-BFBD-A77A0C8F57D3

Q34457638-6B82FE4B-2B81-4B1D-8ADF-7D6E942560A5

Q34457638-70617572-F0C2-4E28-B17F-771BCB746054

Q34457638-88CB9E46-87F9-454D-A8AF-D10576CF78DC

P2860

Q34457638-03242388-FCAD-4C09-9CF7-35E27FAA677A

Q34457638-04A4E39A-EA13-4270-BB51-7A3213F755F7

Q34457638-276905B3-2977-4509-8371-4AB65190D675

Q34457638-3707D94D-8180-41B1-9B01-3A095D317F55

Q34457638-3797455C-D4C3-478A-B376-EC18AEE09879

Q34457638-39C12E4D-A941-4F4A-BBA8-558330998685

Q34457638-4B26F8CD-A103-417C-8E0D-10E3C52B006A

Q34457638-5CCA834E-A96B-4295-9054-0161924817FE

Q34457638-7D7ADD0C-4B78-4A99-909B-AE050D69C8B2

Q34457638-7FF89453-D597-4075-AEAC-369DAFCF526B

P304

Q34457638-F151FF3E-F539-4A7F-9030-8B9A786ADA6C

P31

Q34457638-81960639-4305-45B9-8836-0FACB60F2811

P356

Q34457638-0B3EE20C-A411-48EF-A5A1-A84005C3AF73

P433

Q34457638-EE5C4151-8346-45ED-A285-F978C730B9CB

P478

Q34457638-C53E0ECE-553D-40A8-88E3-6EB343FF4827

P50

Q34457638-0FB3D99F-1A09-49C5-A6EB-0936AB8E94E9

Q34457638-20BCA977-31A0-4C49-A401-169C3BAEA806

Q34457638-60D2811E-9574-4915-BFA0-3A1200C21651

Q34457638-F2806610-8E76-4B55-8BA3-3E11B5D32EC3

Q34457638-F5177CF9-8AA8-4D30-BED0-E4224DCAC9E3

P577

Q34457638-941C7C1E-70FC-40AA-87D9-CE3DAA41045D

P5875

Q34457638-B5BB5AF5-FDC5-4000-AB65-DB117A2048C4

P698

Q34457638-25216DC5-348B-4801-A7D6-6338D83AA784

P932

Q34457638-5FB967B3-D8FA-446B-8830-C3B86F62B914

P356

J.MOLONC.2014.12.003

P1433

Molecular Oncology

P1476

Circulating tumor DNA as a non ...... trial across all tumor types.

@en

P2093

Adrien Saliou

http://www.w3.org/2001/XMLSchema#string

Anthony Blin

http://www.w3.org/2001/XMLSchema#string

Charles Decraene

http://www.w3.org/2001/XMLSchema#string

Céline Callens

http://www.w3.org/2001/XMLSchema#string

Etienne Rouleau

http://www.w3.org/2001/XMLSchema#string

Gaëlle Pierron

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Pierga

http://www.w3.org/2001/XMLSchema#string

Jordan Madic

http://www.w3.org/2001/XMLSchema#string

Maud Kamal

http://www.w3.org/2001/XMLSchema#string

Quentin Leroy

http://www.w3.org/2001/XMLSchema#string

P2860

Liquid biopsies: genotyping circulating tumor DNA

Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

Circulating mutant DNA to assess tumor dynamics

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Detection of circulating tumor DNA in early- and late-stage human malignancies

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives.

P304

783-790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLONC.2014.12.003

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

François-Clément Bidard

Christophe Le Tourneau

Marc-Henri Stern

P577

2014-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270825965

http://www.w3.org/2001/XMLSchema#string

P698

25579085

http://www.w3.org/2001/XMLSchema#string

P932

5528781

http://www.w3.org/2001/XMLSchema#string